Literature DB >> 29637444

Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration.

Yuhai Zhao1,2, Walter J Lukiw3,4,5.   

Abstract

The gram-negative facultative anaerobe Bacteroides fragilis (B. fragilis) constitutes an appreciable proportion of the human gastrointestinal (GI)-tract microbiome. As is typical of most gram-negative bacilli, B. fragilis secretes an unusually complex mixture of neurotoxins including the extremely pro-inflammatory lipopolysaccharide BF-LPS. LPS (i) has recently been shown to associate with the periphery of neuronal nuclei in sporadic Alzheimer's disease (AD) brain and (ii) promotes the generation of the inflammatory transcription factor NF-kB (p50/p65 complex) in human neuronal-glial cells in primary-culture. In turn, the NF-kB (p50/p65 complex) strongly induces the transcription of a small family of pro-inflammatory microRNAs (miRNAs) including miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, and miRNA-155. These ultimately bind with the 3'-untranslated region (3'-UTR) of several target messenger RNAs (mRNAs) and thereby reduce their expression. Down-regulated mRNAs include those encoding complement factor-H (CFH), an SH3-proline-rich multi-domain-scaffolding protein of the postsynaptic density (SHANK3), and the triggering receptor expressed in myeloid/microglial cells (TREM2), as is observed in sporadic AD brain. Hence, a LPS normally confined to the GI tract is capable of driving a NF-kB-miRNA-mediated deficiency in gene expression that contributes to alterations in synaptic-architecture and synaptic-deficits, amyloidogenesis, innate-immune defects, and progressive inflammatory signaling, all of which are characteristics of AD-type neurodegeneration. This article will review the most recent research which supports the idea that bacterial components of the GI tract microbiome such as BF-LPS can transverse biophysical barriers and contribute to AD-type change. For the first-time, these results indicate that specific GI tract microbiome-derived neurotoxins have a strong pathogenic role in eliciting alterations in NF-kB-miRNA-directed gene expression that drives the AD process.

Entities:  

Keywords:  Alzheimer’s disease; Amyloidogenesis; Bacteroides fragilis; Lipopolysaccharide; Messenger RNA; Microbiome; Neuroinflammation; Phagocytosis; Synaptogenesis; microRNA

Mesh:

Substances:

Year:  2018        PMID: 29637444     DOI: 10.1007/s12035-018-1015-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  36 in total

1.  Aluminum-induced generation of lipopolysaccharide (LPS) from the human gastrointestinal (GI)-tract microbiome-resident Bacteroides fragilis.

Authors:  P N Alexandrov; J M Hill; Y Zhao; T Bond; C M Taylor; M E Percy; W Li; W J Lukiw
Journal:  J Inorg Biochem       Date:  2019-10-22       Impact factor: 4.155

Review 2.  Subacute Neuropsychiatric Syndrome in Girls With SHANK3 Mutations Responds to Immunomodulation.

Authors:  Alexandra L Bey; Mark P Gorman; William Gallentine; Teresa M Kohlenberg; Jennifer Frankovich; Yong-Hui Jiang; Keith Van Haren
Journal:  Pediatrics       Date:  2020-02       Impact factor: 7.124

3.  Aluminum in Neurological and Neurodegenerative Disease.

Authors:  Donald R C McLachlan; Catherine Bergeron; Peter N Alexandrov; William J Walsh; Aileen I Pogue; Maire E Percy; Theodore P A Kruck; Zhide Fang; Nathan M Sharfman; Vivian Jaber; Yuhai Zhao; Wenhong Li; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

Review 4.  Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.

Authors:  Priyanka Nagu; Arun Parashar; Tapan Behl; Vineet Mehta
Journal:  J Mol Neurosci       Date:  2021-04-08       Impact factor: 3.444

5.  Changes in activity of µ- and m-calpains and signs of neuroinflammation in the hippocampus and striatum of rats after single intraperitoneal injection of subseptic dose of endotoxin.

Authors:  Viktoriya Maystrenko; Irina Ivleva; Darya Krytskaya; Alexander Zubov; Andrey Ivlev; Marina Karpenko
Journal:  Metab Brain Dis       Date:  2021-05-20       Impact factor: 3.584

Review 6.  Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?

Authors:  Manuel H Janeiro; María J Ramírez; Maite Solas
Journal:  Cell Mol Neurobiol       Date:  2021-01-05       Impact factor: 5.046

Review 7.  Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.

Authors:  Tamas Fulop; Shreyansh Tripathi; Serafim Rodrigues; Mathieu Desroches; Ton Bunt; Arnold Eiser; Francois Bernier; Pascale B Beauregard; Annelise E Barron; Abdelouahed Khalil; Adam Plotka; Katsuiku Hirokawa; Anis Larbi; Christian Bocti; Benoit Laurent; Eric H Frost; Jacek M Witkowski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-04       Impact factor: 2.570

8.  Gut microbial involvement in Alzheimer's disease pathogenesis.

Authors:  Yu Zhang; Rulin Geng; Qiuyun Tu
Journal:  Aging (Albany NY)       Date:  2021-05-10       Impact factor: 5.682

9.  Changes in Gut Microbiome Associated With Co-Occurring Symptoms Development During Chemo-Radiation for Rectal Cancer: A Proof of Concept Study.

Authors:  Velda J González-Mercado; Wendy A Henderson; Anujit Sarkar; Jean Lim; Leorey N Saligan; Lawrence Berk; Larry Dishaw; Susan McMillan; Maureen Groer; Farrah Sepehri; Gail D'Eramo Melkus
Journal:  Biol Res Nurs       Date:  2020-07-23       Impact factor: 2.522

10.  Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer's disease by meta-analysis and adaptive boosting ensemble learning.

Authors:  Sze Chung Yuen; Xiaonan Liang; Hongmei Zhu; Yongliang Jia; Siu-Wai Leung
Journal:  Alzheimers Res Ther       Date:  2021-07-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.